<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteBiotechnology &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/biotechnology/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>David Walt named as laureate for National Medal of Technology and Innovation</title>
				<link>https://wyss.stage.a17.io/news/david-walt-named-as-laureate-for-national-medal-of-technology-and-innovation/</link>
        <pubDate>Tue, 07 Jan 2025 14:52:56 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[Wyss DxA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41781</guid>
                            <description>The award is the nation’s highest honor for technological achievement, bestowed by the president of the United States on America’s leading innovators</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; On January 3, Wyss Institute Core Faculty member David Walt, Ph.D., who also is a Professor of Pathology at Boston&rsquo;s Brigham and Women&rsquo;s Hospital (BWH), the Hansj&ouml;rg Wyss Professor of Biologically Inspired Engineering at Harvard Medical School (HMS), an Associate member at the Broad Institute, and a Howard Hughes Medical Institute Professor&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/david-walt-named-as-laureate-for-national-medal-of-technology-and-innovation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/david-walt-named-as-laureate-for-national-medal-of-technology-and-innovation/</link>
          <title>Arati Prabhakar, Ph.D., Director of the White House Office of Science and Technology Policy (OSTP), awards David Walt the Medal of Technology and Innovation during an awards ceremony at the Eisenhower Executive Office Building in Washington, DC, January 3, 2025. Credit: Ryan K. Morris</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2025/01/06143831/David-R.-Walt-1920x1278.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=edb8cb18574c2549ec8f6bec8711bd1e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Researchers call for global discussion about possible risks from “mirror bacteria”</title>
				<link>https://wyss.stage.a17.io/news/researchers-call-for-global-discussion-about-possible-risks-from-mirror-bacteria/</link>
        <pubDate>Wed, 18 Dec 2024 14:27:15 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41721</guid>
                            <description>Paper represents the beginning of a dialogue to better understand and mitigate potential impacts of organisms with reversed chirality</description>
                                        <content:encoded><![CDATA[<p>A group of researchers including Wyss Core Faculty member George Church, Ph.D. has published new findings in Science on potential risks from the development of mirror bacteria &mdash; synthetic organisms in which all molecules have reversed chirality (i.e. are &lsquo;mirrored&rsquo;). Scientists had begun early work toward creating mirror bacteria, and while the capability is at least a decade away&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/researchers-call-for-global-discussion-about-possible-risks-from-mirror-bacteria/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/researchers-call-for-global-discussion-about-possible-risks-from-mirror-bacteria/</link>
          <title>Credit: Envato Elements/wirestock</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/16103103/doctor-holding-petri-dish-with-microbe-colony-2023-11-27-05-02-30-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f1bd8ff68dd21808c277000d9cdd7488"/></url>
				</image>
        			</item>

		
			<item>
				<title>Innovative tissue engineering: ESCAPE, a pioneering new method explained</title>
				<link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:31 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41664</guid>
                            <description>Molding complex tissues using gallium</description>
                                        <content:encoded><![CDATA[<p>By Boston University Communications (BOSTON) &mdash; When it comes to the human body, form and function work together. The shape and structure of our hands enable us to hold and manipulate things. Tiny air sacs in our lungs called alveoli allow for air exchange and help us breath in and out. And tree&#x2d;like blood vessels branch throughout our body, delivering oxygen from our head to our toes.</p>
<p><a href="https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/10165502/12_Cast-with-ring_CROP.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=973cd27dff9e57118ca795750c18a7fa"/></url>
				</image>
        			</item>

		
			<item>
				<title>ESCAPE Bioengineering</title>
				<link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41676</guid>
                                                <content:encoded><![CDATA[<p>A research team at the Wyss Institute and Boston University has developed ESCAPE, the first method that enables the engineering of tissues across multiple length scales, ranging from the diameter of a cell to the cm scale of a heart valve. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/escape-bioengineering/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/11082233/THUMBNAIL_Escape-Bioengineering_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3670be8864105a406ec4c303a084839d"/></url>
				</image>
        			</item>

		
			<item>
				<title>Closing in on Parkinson’s Disease proteins in extracellular vesicles in the blood</title>
				<link>https://wyss.stage.a17.io/news/closing-in-on-parkinsons-disease-proteins-in-extracellular-vesicles-in-the-blood/</link>
        <pubDate>Fri, 01 Nov 2024 13:20:38 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41390</guid>
                            <description>Precision diagnostics for diseases that affect the brain and other organs brought closer by new ability to exclusively access contents of organ-derived extracellular vesicles in blood</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Brain disorders like Parkinson&rsquo;s (PD) or Alzheimer&rsquo;s Disease (AD) start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their disease, but there is currently no way to diagnose brain disorders at those pre&#x2d;symptomatic stages. Thus far, the specific brain lesions&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/closing-in-on-parkinsons-disease-proteins-in-extracellular-vesicles-in-the-blood/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/closing-in-on-parkinsons-disease-proteins-in-extracellular-vesicles-in-the-blood/</link>
          <title>Researchers at the Wyss Institute and collaborating institutions moved the needle on using extracellular vesicle (EVs) as a rich source of biomarkers for Parkinson’s Disease and other disorders of the brain and other organs. By advancing their “liquid biopsy” platform, they developed the ability to, for the first time, exactly answer the simple but challenging question of what portion of a given protein present in blood plasma is actually inside of EVs relative to outside. Credit: Shutterstock/Arif biswas</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/10/31094205/shutterstock_2207662035.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d1128ae47eb6725010099cbbdc6b436b"/></url>
				</image>
        			</item>

		
			<item>
				<title>CRISPR&#8217;s Impact, Today</title>
				<link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
        <pubDate>Mon, 21 Oct 2024 12:00:08 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Editas Inc.]]></category>
		<category><![CDATA[eGenesis]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40926</guid>
                            <description>Keeping CRISPR’s promise for patients in need</description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &mdash; In the not&#x2d;so&#x2d;distant past, CRISPR, the revolutionary gene&#x2d;editing technology, was discovered as a defense system protecting bacteria against viruses. Today, with the persistence and ingenuity of many scientists, it is no longer just the subject of fascinating academic research papers and speculative discussions on its future usefulness for medicine.</p>
<p><a href="https://wyss.stage.a17.io/news/crisprs-impact-today/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
          <title>Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. CREDITS: Michelle Rose/Massachusetts General Hospital</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09093712/20240403_mcr_transplant_patient_010-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=911871f7428259dbd6ffadedb29de92e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies</title>
				<link>https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/</link>
        <pubDate>Wed, 02 Oct 2024 13:20:13 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41088</guid>
                            <description>The startup is leveraging the biomaterial-based technology to develop novel therapies able to program anti-cancer immunity and prevent infectious diseases</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has licensed a portfolio of immune&#x2d;modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/</link>
          <title> The OMNIVAX infection vaccine approach incorporates pathogen-derived antigens into an injectable biomaterial scaffold which presents them together with immune cell attracting and activating factors to dendritic immune cells that then go on to orchestrate multi-faceted immune responses against the pathogen in nearby lymph nodes. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/05/20143742/MPS-Scaffold-SEM-001-e1590000157764.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b22cd283948c2a998b8ada8474c9e03f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Eliz Amar Lewis on Using Many Tools to Fight a Sophisticated Disease</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-eliz-amar-lewis-on-using-many-tools-to-fight-a-sophisticated-disease/</link>
        <pubDate>Tue, 24 Sep 2024 14:50:19 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[RNA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41047</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Eliz Amar Lewis has always been fascinated by biology. But when she saw her grandmother bravely battle breast cancer, she was inspired to use her passion to develop a smart and sophisticated&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-eliz-amar-lewis-on-using-many-tools-to-fight-a-sophisticated-disease/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-eliz-amar-lewis-on-using-many-tools-to-fight-a-sophisticated-disease/</link>
          <title>Eliz Amar Lewis, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/23140755/dsRNA-Eliz-Amar-Lewis-07336.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=8f758cb4d1a3a71b4ba9df3c9617f9a3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Preventing pollution with bioinspired solutions</title>
				<link>https://wyss.stage.a17.io/news/preventing-pollution-with-bioinspired-solutions/</link>
        <pubDate>Tue, 17 Sep 2024 21:14:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Michael Springer]]></category>
		<category><![CDATA[Pamela Silver]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41014</guid>
                            <description>Three Wyss projects aim to reduce global pollution through better detection, greener alternatives, and creating value from waste</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell In honor of Pollution Prevention Week, we&rsquo;re highlighting three Wyss projects that are taking on the formidable problems of PFAS and plastic &ndash; persistent and toxic pollutants that threaten the health of humans, animals, and ecosystems. Per&#x2d; and polyfluoroalkyl substances (PFAS), or &ldquo;forever chemicals,&rdquo; are toxic substances that increase the risk of many health&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/preventing-pollution-with-bioinspired-solutions/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/preventing-pollution-with-bioinspired-solutions/</link>
          <title>Caption</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/17121336/top-view-of-globe-in-plastic-bag-with-garbage-arou-2023-11-27-05-24-14-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f2ae1fb94b0aad11528ff3070f87737b"/></url>
				</image>
        			</item>

		
			<item>
				<title>3D-printed blood vessels bring artificial organs closer to reality</title>
				<link>https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/</link>
        <pubDate>Wed, 07 Aug 2024 16:55:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Bioprinting]]></category>
		<category><![CDATA[Extracellular Matrix]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40723</guid>
                            <description>New printing method creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro </description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Growing functional human organs outside the body is a long&#x2d;sought &ldquo;holy grail&rdquo; of organ transplantation medicine that remains elusive. New research from Harvard&rsquo;s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Science (SEAS) brings that quest one big step closer to completion. A team of scientists&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/</link>
          <title>A new technique that builds on SWIFT, called co-SWIFT, creates branched vascular channels to more accurately replicate the structure of naturally occurring blood vessels. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/06114145/printedVesselNetwork.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5093bd0c1f6aeaa736eaaa9c40b5967c"/></url>
				</image>
        			</item>

			</channel>
</rss>
